Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Cencora, Inc. (COR) trades at a P/S ratio of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (November 2025); the current reading is higher than 96% of that period. That is below the Medical Distribution industry median of 0.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.2× 24.01%
FY2024 0.2× 9.91%
FY2023 0.1× 17.01%
FY2022 0.1× 2.87%
FY2021 0.1× 9.95%
FY2020 0.1× 8.52%
FY2019 0.1× (20.02%)
FY2018 0.1× 1.35%
FY2017 0.1× 1.80%
FY2016 0.1× (23.32%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 0.2× (11.67%)
Mar 2026 0.2× (7.70%)
Dec 2025 0.2× 6.84%
Sep 2025 0.2× 2.72%
42 more quarters

Against its own ten years

Low 0.1× High 0.2×
Ten-year median 0.1×
Current reading's percentile 96

P/S ratio against peers

Company P/S ratio
ACH Accendra Health, Inc. compare 0.0×
COR Cencora, Inc. 0.2×
CAH Cardinal Health, Inc. compare 0.2×
COSM Cosmos Health Inc. compare 0.3×
MCK McKesson Corporation compare 0.3×
HSIC Henry Schein, Inc. compare 0.7×
AHG Akso Health Group Sponsored ADR compare 1.1×
FOCL FocalTherics compare 1.9×
HKPD Cellyan Biotechnology Co., Ltd compare —
Medical Distribution industry median 0.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on COR